Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Chamberlain

Showing results (131-140 of 244) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Is graded prognostic assessment an improvement compared with radiation therapy oncology group's recursive partitioning analysis classification for brain metastases?Marc C Chamberlain, Daniel L Silbergeld
The Oncologist|September 24, 2013
Is there a role for bevacizumab in the treatment of glioblastoma?Andrew S Chi, Marc C Chamberlain
Journal of Neuro-Oncology|May 16, 2008
CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendrogliomaMarc C Chamberlain, Michael J Glantz
Cancer Chemotherapy and Pharmacology|May 28, 2008
Renal dysfunction during and after high-dose methotrexateMyke R Green, Marc C Chamberlain
Neurosurgical Focus|December 18, 2007
Adjuvant therapy for unresectable meningiomas: benign and malignantThomas C Chen, Marc C Chamberlain
Current Neurology and Neuroscience Reports|March 21, 2013
Brainstem glioma: a reviewSean A Grimm, Marc C Chamberlain
Cancer Treatment and Research|October 11, 2005
Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom managementStacey L Berg, Marc C Chamberlain
Journal of Neuro-Oncology|June 1, 2011
Salvage therapy with single agent bendamustine for recurrent glioblastomaMarc C Chamberlain, Sandra K Johnston
Journal of Neuro-Oncology|February 15, 2011
Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case seriesMarc C Chamberlain, Sandra K Johnston
Neurosurgery|November 5, 2008
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytomaMarc C Chamberlain, Michael J Glantz
Pageof 25

Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Is graded prognostic assessment an improvement compared with radiation therapy oncology group's recursive partitioning analysis classification for brain metastases?Marc C Chamberlain, Daniel L Silbergeld
The Oncologist|September 24, 2013
Is there a role for bevacizumab in the treatment of glioblastoma?Andrew S Chi, Marc C Chamberlain
Journal of Neuro-Oncology|May 16, 2008
CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendrogliomaMarc C Chamberlain, Michael J Glantz
Cancer Chemotherapy and Pharmacology|May 28, 2008
Renal dysfunction during and after high-dose methotrexateMyke R Green, Marc C Chamberlain
Neurosurgical Focus|December 18, 2007
Adjuvant therapy for unresectable meningiomas: benign and malignantThomas C Chen, Marc C Chamberlain
Current Neurology and Neuroscience Reports|March 21, 2013
Brainstem glioma: a reviewSean A Grimm, Marc C Chamberlain
Cancer Treatment and Research|October 11, 2005
Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom managementStacey L Berg, Marc C Chamberlain
Journal of Neuro-Oncology|June 1, 2011
Salvage therapy with single agent bendamustine for recurrent glioblastomaMarc C Chamberlain, Sandra K Johnston
Journal of Neuro-Oncology|February 15, 2011
Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case seriesMarc C Chamberlain, Sandra K Johnston
Neurosurgery|November 5, 2008
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytomaMarc C Chamberlain, Michael J Glantz
Pageof 25